Concepedia

Kunihiko Hinohara

KH

36

Publications

3.3K

Citations

25

H-Index

2007

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Tokyo Medical and Dental University

Nagoya University

The University of Tokyo

Kunihiko Hinohara is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2007–2024

36

Publications

36

Genetic and transcriptional evolution alters cancer cell line drug response

Uri Ben‐David, Benjamin A. Siranosian, Gavin Ha et al. · Nature · 2018 · 890 citations · Full text

, , +9

MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer

Takahiro Maeda, Masayuki Hiraki, Caining Jin et al. · Cancer Research · 2017 · 264 citations · Full text

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance

Kunihiko Hinohara, Hua‐Jun Wu, Sébastien Vigneau et al. · Cancer Cell · 2018 · 248 citations · Full text

, , +9

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge et al. · Molecular Cell · 2020 · 197 citations · Full text

, , +9

Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression

Kazumasa Komura, Seong Ho Jeong, Kunihiko Hinohara et al. · Proceedings of the National Academy of Sciences · 2016 · 160 citations · Full text

Rows per page

1–5 of 36